Replimune Group, Inc., a clinical-stage biotechnology company, focuses on the development and commercialization of oncolytic immunotherapies to treat cancer. The company’s proprietary oncolytic ...
OpenAI just revealed what its new in-house team, OpenAI for Science, has been up to. The firm has released a free LLM-powered ...
Chris Pratt recently told Entertainment Weekly that he suggested an AI “actor” play the tyrannical AI judge in his new sci-fi ...
Koi security researchers found that when NPM installs a dependency from a Git repository, configuration files such as a ...
22hOpinion
Where AI browsers fall short
Unlike regular search engines, AI browsers suffer from algorithmic inconsistency due to their black-box nature — and even ...
Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer. The company was founded by Philip ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results